TrialFrontiers in immunology2025

Proteins linked to type II interferon response in Sjögren's disease: novel indicators for disease monitoring and predicting treatment response to leflunomide and hydroxychloroquine combination therapy.

Wing-Yi Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.